Protective antibodies against human parainfluenza virus type 3 infection
Human parainfluenza virus type III (HPIV3) is a common respiratory pathogen that afflicts children and can be fatal in vulnerable populations, including the immunocompromised. There are currently no effective vaccines or therapeutics available, resulting in tens of thousands of hospitalizations per...
Saved in:
Main Authors: | Jim Boonyaratanakornkit (Author), Suruchi Singh (Author), Connor Weidle (Author), Justas Rodarte (Author), Ramasamy Bakthavatsalam (Author), Jonathan Perkins (Author), Guillaume B.E. Stewart-Jones (Author), Peter D. Kwong (Author), Andrew T. McGuire (Author), Marie Pancera (Author), Justin J. Taylor (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Human parainfluenza virus surveillance in pediatric patients with lower respiratory tract infections: a special view of parainfluenza type 4
by: Luciano M. Thomazelli, et al.
Published: (2018) -
Human parainfluenza virus surveillance in pediatric patients with lower respiratory tract infections: a special view of parainfluenza type 4
by: Luciano M. Thomazelli, et al.
Published: (2018) -
A case of acute necrotizing encephalopathy associated with parainfluenza virus infection
by: Yoo-Na Kim, et al.
Published: (2012) -
Rhabdomyolysis due to parainfluenza 3 virus infection: Case report and review of literature
by: Radhika Kolpuke, et al.
Published: (2019) -
Changes in epidemiology of parainfluenza virus and respiratory syncytial virus infection during coronavirus disease 2019 pandemic in Korea
by: Kyung-Ran Kim, et al.
Published: (2022)